The U.S. Food and Drug Administration has approved a second screening test for West Nile Virus disease for use in donated blood and organs.
The cobas TaqScreen WNV test is an automated test that's able to detect the genetic material of the virus itself early during the infection process, the FDA said. The nucleic acid testing detects whether donated blood and organs have been infected, even if the donor's body hasn't begun to produce antibodies against the virus.
West Nile Virus is most often transmitted to humans by mosquitoes but it can also be transmitted through blood transfusion or organ transplantation from infected donors.
The approval means blood centers and hospitals will have a choice of two FDA-approved tests, said Dr. Jesse Goodman, director of the FDA's Center for Biologics Evaluation and Research.
The newly approved test is manufactured by Roche Molecular Systems Inc. of Pleasanton, Calif.
Copyright 2007 by United Press International
Related stories:
10,000 people in world-first cerebral palsy study
Researchers from the University of Adelaide, Australia, have launched the largest study of its kind in the world in a bid to better understand the possible genetic causes of cerebral palsy.
Researchers from 5 countries to test hygiene hypothesis
Why do Finnish children have type 1 diabetes and allergic symptoms approximately 5 times more often than children in Russian Karelia?
Scripps Research Institute awarded patent for remarkable chemical technology
The patent's diverse potential applications include the development of new drugs, bioactive nanomaterials, anti-bacterial and non-immunogenic coatings for medical implants, coatings for semiconductors, coatings and adhesives for ships’ hulls, self-healing materials, microelectronics and responsive nanomaterials, and surface-sensitive adhesives, to name a few.
Researchers find smallpox drug may also target adenovirus
Scientists at Saint Louis University have made two key discoveries that could lead to the first-ever human testing of a drug to target the adenovirus, which causes a number of severe upper-respiratory infections and is one of many viruses that causes the common cold.
Researchers develop improved gene therapy agent
Replacing one amino acid on the surface of a virus that shepherds corrective genes into cells could be the breakthrough scientists have needed to make gene therapy a more viable option for treating genetic diseases such as hemophilia, University of Florida researchers say.
Personalized therapy for asthma and COPD could soon be here
Researchers at Washington University School of Medicine in St. Louis have defined a new type of immune response that is activated in patients with severe asthma and COPD (chronic obstructive pulmonary disease). Their discovery could dramatically improve diagnosis and treatment of patients with chronic inflammatory lung disease.
New treatment for hepatitis C
Researchers at the University of Oklahoma Health Sciences Center have found a new use for an old drug. Their findings appear online in the
American Journal of Gastroenterology.
Research findings open new front in fight against AIDS virus
A research group supported by the National Institutes of Health (NIH) has uncovered a new route for attacking the human immunodeficiency virus (HIV) that may offer a way to circumvent problems with drug resistance. In findings published today in the online edition of the
Proceedings of the National Academy of Sciences, the researchers report that they have blocked HIV infection in the test tube by inactivating a human protein expressed in key immune cells.